
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html
解鎖市場時間軸與訊號動態
過去 90 日內有 154 個訊號。
此公司進入各市場的次序 — 由最舊至最新
89 active postings
48 active postings
註冊以查看完整訊號動態
Bristol Myers Squibb 的國際擴張與競爭對手的比較
長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
Bristol Myers Squibb你 | 22 | 2 | +40% | 139 | 36 |
Senior Manager, Commercial AI & Digital Solutions
查看招聘Seoul, Seoul, South Korea · 昨日
EG-090 - Clinical Research Associate
查看招聘Beijing, Beijing, China · 昨日
Director, Data Engineering & Analytics
查看招聘Devens, MA · 上星期
Hiring Now: Advance Meaningful Work in Clinical Trials
已結束Drive Analytics That Shape Global Research
已結束Hiring Now: Join the Future of Neuroscience
已結束和鉑醫藥任命Adam Zong博士為總裁,負責加強產品管線、推進組合策略及領導合作夥伴關係。Zong擁有超過20年生物製藥經驗,曾任職默克、百時美施貴寶、輝瑞及恒瑞醫藥。
紐交所提供開市前更新,包括英偉達盈利、漢堡王AI助手、以及即將與Lumen和Phinia CEO進行的NYSE Live訪談。
三分之一的風濕病專家認為BMS的Sotyktu是銀屑病關節炎治療的重大進展,具有強烈的上市前認知度,並在安全性方面與JAK抑制劑有所區別。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Bristol Myers Squibb 業務、市場及增長訊號的快速解答。
